Spots Global Cancer Trial Database for gall bladder cancer

Every month we try and update this database with for gall bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent	NCT01875549	Obstruction of ... Cholangiocarcin... Hepatocellular ... Malignant Lymph... Gall Bladder Ca...	stent insertion Endoscopic retr...	18 Years -	Samsung Medical Center
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.	NCT05102110	Non Small Cell ... Gastric Adenoca... Pancreatic Canc... Gall Bladder Ca... Bladder Cancer	Oricol Test	18 Years - 99 Years	Origin Sciences
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer	NCT01016639	Stomach Cancer Gall Bladder Ca... Bile Ductus Can... Pancreas Cancer Colorectal Canc...	oxaliplatin, ca...	18 Years -	Lund University Hospital
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering	NCT04426669	Gastrointestina... Gastrointestina... Cancer of Gastr... Cancer, Gastroi... Gastrointestina... Colo-rectal Can... Pancreatic Canc... Gall Bladder Ca... Colon Cancer Esophageal Canc... Stomach Cancer	Cyclophosphamid... Fludarabine Tumor-Infiltrat... Aldesleukin	18 Years - 70 Years	Intima Bioscience, Inc.
Robotic-assisted Contra Open Resection for Suspected or Confirmed Gallbladder Cancer (ROBOCOP)	NCT06246448	Gall Bladder Ca...	Robotic-assiste... Open radical ch...	18 Years -	Karolinska University Hospital
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor	NCT03985072	Tumor, Solid Gall Bladder Ca... Cervical Cancer Gastric Cancer Pancreatic Canc... Colorectal Canc...	Andes-1537 for ...	18 Years -	Andes Biotechnologies
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos	NCT03668418	Liver Cancer Pancreatic Canc... Gastric Cancer Esophageal Canc... Colo-rectal Can... Gall Bladder Ca... Biliary Tract C...	Fluorouracil Lederfolin Oxaliplatin Irinotecan Docetaxel Cisplatin Epirubicin Gemcitabine Nab paclitaxel	18 Years -	University of Pisa
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer	NCT01016639	Stomach Cancer Gall Bladder Ca... Bile Ductus Can... Pancreas Cancer Colorectal Canc...	oxaliplatin, ca...	18 Years -	Lund University Hospital
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors	NCT05712356	Cholangiocarcin... Gallbladder Can... Gallbladder Car... Intrahepatic Ch... Extrahepatic Ch... Bile Duct Cance... Gall Bladder Ca... Gall Bladder Ca...	LSTA1 Durvalumab Cisplatin Gemcitabine FOLFOX regimen Placebo	18 Years -	Lisata Therapeutics, Inc.
Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent	NCT01875549	Obstruction of ... Cholangiocarcin... Hepatocellular ... Malignant Lymph... Gall Bladder Ca...	stent insertion Endoscopic retr...	18 Years -	Samsung Medical Center
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types	NCT05000294	Bile Duct Cance... Gall Bladder Ca... Breast Cancer Neuroendocrine ... Ovarian Cancer Pancreatic Aden... Soft Tissue Sar... Vulvar Cancer Prostate Cancer	Atezolizumab Tivozanib	18 Years - 99 Years	University of Florida
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo	NCT00332280	Gastrointestina... Prostate Cancer Genital Neoplas...	AMT2003	18 Years - 79 Years	Auron Healthcare GmbH
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)	NCT05506943	Biliary Tract C... Cholangiocarcin... Gall Bladder Ca... Ampullary Cance...	CTX-009 Paclitaxel	18 Years -	Compass Therapeutics
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo	NCT00332280	Gastrointestina... Prostate Cancer Genital Neoplas...	AMT2003	18 Years - 79 Years	Auron Healthcare GmbH
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection	NCT04856761	Biliary Tract N... Recurrence Cholangiocarcin... Gall Bladder Ca...	S-1 Capecitabine	18 Years - 75 Years	Fudan University
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)	NCT06101277	Esophageal Canc... Small Bowel Can... Gastroesophagea... Gastric Cancer Colorectal Canc... Appendiceal Can... Biliary Cancer Gall Bladder Ca... Intrahepatic Ch... Extrahepatic Ch... Oligoprogressiv...	Ablative local ...	18 Years -	University of California, Davis
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors	NCT00090025	Biliary Tract C...	becatecarin 5-Fluorouracil ...	18 Years -	Helsinn Healthcare SA
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)	NCT05506943	Biliary Tract C... Cholangiocarcin... Gall Bladder Ca... Ampullary Cance...	CTX-009 Paclitaxel	18 Years -	Compass Therapeutics
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer	NCT01016639	Stomach Cancer Gall Bladder Ca... Bile Ductus Can... Pancreas Cancer Colorectal Canc...	oxaliplatin, ca...	18 Years -	Lund University Hospital
B-Receptor Signaling in Cardiomyopathy	NCT01135849	Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer		- 40 Years	Stanford University
B-Receptor Signaling in Cardiomyopathy	NCT01135849	Carcinomas Amyloidosis Anal Cancer Anemia Cholangiocarcin... Transitional Ce... Bone Marrow Tra... Bone Cancer Cancer of Brain... Breast Cancer Carcinoma of th... Endocrine Cance... Esophageal Canc... Eye Cancer Gall Bladder Ca... Gastric (Stomac... Gastrooesophage... Gastrointestina... Gynecologic Can... Head and Neck C... Hepatobiliary N... Kidney (Renal C... Leukemia Lung Cancer Hodgkin Disease Lymphoma, Non-H... Mesothelioma Multiple Myelom... Myelodysplastic... Neuroendocrine ... Myeloproliferat... Pancreatic Canc... Prostate Cancer Skin Cancer Soft Tissue Sar... Testicular Canc... Thymus Cancer Thyroid Cancer		- 40 Years	Stanford University

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: